IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $845,376 | +569.1% | 44,800 | +36.2% | 0.00% | – |
Q1 2023 | $126,336 | -91.7% | 32,900 | -87.7% | 0.00% | -100.0% |
Q3 2021 | $1,522,000 | +233.0% | 268,500 | +376.1% | 0.00% | +300.0% |
Q1 2021 | $457,000 | +25.5% | 56,400 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $364,000 | +79.3% | 56,400 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $203,000 | -86.1% | 56,400 | -82.2% | 0.00% | -66.7% |
Q2 2020 | $1,460,000 | +34.9% | 317,400 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,082,000 | +47.8% | 317,400 | +121.6% | 0.00% | +200.0% |
Q4 2019 | $732,000 | +781.9% | 143,200 | +365.8% | 0.00% | – |
Q1 2019 | $83,000 | -69.0% | 30,744 | -44.9% | 0.00% | -100.0% |
Q4 2018 | $268,000 | +37.4% | 55,844 | +179.1% | 0.00% | 0.0% |
Q2 2018 | $195,000 | 0.0% | 20,007 | +7.9% | 0.00% | 0.0% |
Q1 2018 | $195,000 | -83.2% | 18,544 | -89.8% | 0.00% | -80.0% |
Q4 2017 | $1,163,000 | +87.3% | 181,400 | +123.4% | 0.01% | +66.7% |
Q3 2017 | $621,000 | -71.6% | 81,200 | -73.6% | 0.00% | -70.0% |
Q2 2017 | $2,188,000 | +1010.7% | 307,800 | +504.7% | 0.01% | +900.0% |
Q1 2017 | $197,000 | – | 50,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
Grace Capital | 49,500 | $228,000 | 0.20% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |